(Q45383963)

14 December 2017

title

PCSK9 impedes hepatitis C virus infection in vitro and modulates liver CD81 expression (English)

1 reference

14 December 2017

1 reference

1 reference

8

1 reference

14 December 2017

Annik Prat

7

0 references

author name string

Patrick Labonté

1

1 reference

14 December 2017

Syntia Begley

2

1 reference

14 December 2017

Carl Guévin

3

1 reference

14 December 2017

Marie-Claude Asselin

4

1 reference

14 December 2017

Nasha Nassoury

5

1 reference

14 December 2017

Gaétan Mayer

6

1 reference

14 December 2017

language of work or name

English

0 references

publication date

1 July 2009

1 reference

14 December 2017

1 reference

14 December 2017

volume

50

1 reference

14 December 2017

issue

1

1 reference

14 December 2017

page(s)

17-24

1 reference

14 December 2017

1 reference

Consensus proposals for a unified system of nomenclature of hepatitis C virus genotypes

21 January 2018

1 reference

How does hepatitis C virus enter cells?

21 January 2018

1 reference

Cell entry of hepatitis C virus

21 January 2018

1 reference

Binding of hepatitis C virus to CD81

21 January 2018

1 reference

The human scavenger receptor class B type I is a novel candidate receptor for the hepatitis C virus

21 January 2018

1 reference

Hepatitis C virus and other flaviviridae viruses enter cells via low density lipoprotein receptor

21 January 2018

1 reference

The tight junction proteins claudin-1, -6, and -9 are entry cofactors for hepatitis C virus

21 January 2018

1 reference

Tight Junction Proteins Claudin-1 and Occludin Control Hepatitis C Virus Entry and Are Downregulated during Infection To Prevent Superinfection

21 January 2018

1 reference

Complete replication of hepatitis C virus in cell culture

21 January 2018

1 reference

Differential Biophysical Properties of Infectious Intracellular and Secreted Hepatitis C Virus Particles

21 January 2018

1 reference

The secretory proprotein convertase neural apoptosis-regulated convertase 1 (NARC-1): liver regeneration and neuronal differentiation

21 January 2018

1 reference

The proprotein convertases are potential targets in the treatment of dyslipidemia

21 January 2018

1 reference

Catalytic activity is not required for secreted PCSK9 to reduce low density lipoprotein receptors in HepG2 cells

21 January 2018

1 reference

NARC-1/PCSK9 and its natural mutants: zymogen cleavage and effects on the low density lipoprotein (LDL) receptor and LDL cholesterol

21 January 2018

1 reference

Mutations in PCSK9 cause autosomal dominant hypercholesterolemia

21 January 2018

1 reference

Low LDL cholesterol in individuals of African descent resulting from frequent nonsense mutations in PCSK9.

21 January 2018

1 reference

Adenoviral-mediated expression of Pcsk9 in mice results in a low-density lipoprotein receptor knockout phenotype

21 January 2018

1 reference

Decreased plasma cholesterol and hypersensitivity to statins in mice lacking Pcsk9

21 January 2018

1 reference

Proprotein convertase subtilisin/kexin type 9 (PCSK9): hepatocyte-specific low-density lipoprotein receptor degradation and critical role in mouse liver regeneration

21 January 2018

1 reference

The proprotein convertase (PC) PCSK9 is inactivated by furin and/or PC5/6A: functional consequences of natural mutations and post-translational modifications

21 January 2018

1 reference

Secreted PCSK9 decreases the number of LDL receptors in hepatocytes and in livers of parabiotic mice

21 January 2018

1 reference

The proprotein convertase PCSK9 induces the degradation of low density lipoprotein receptor (LDLR) and its closest family members VLDLR and ApoER2

21 January 2018

1 reference

CD81 Expression Is Important for the Permissiveness of Huh7 Cell Clones for Heterogeneous Hepatitis C Virus Infection

21 January 2018

1 reference

The cellular trafficking of the secretory proprotein convertase PCSK9 and its dependence on the LDLR

21 January 2018

1 reference

Hepatitis C virus glycoproteins mediate low pH-dependent membrane fusion with liposomes

21 January 2018

1 reference

The CD81 Partner EWI-2wint Inhibits Hepatitis C Virus Entry

21 January 2018

1 reference

Structural characterization of recombinant human CD81 produced in Pichia pastoris

21 January 2018

1 reference

Plasma PCSK9 levels correlate with cholesterol in men but not in women

21 January 2018

1 reference

The Level of CD81 Cell Surface Expression Is a Key Determinant for Productive Entry of Hepatitis C Virus into Host Cells

21 January 2018

1 reference

Molecular characterization of loss-of-function mutations in PCSK9 and identification of a compound heterozygote

21 January 2018

1 reference

Associations between hepatitis C viremia and low serum triglyceride and cholesterol levels: a community-based study

21 January 2018

1 reference

Statins upregulate PCSK9, the gene encoding the proprotein convertase neural apoptosis-regulated convertase-1 implicated in familial hypercholesterolemia

21 January 2018

1 reference

Correlation between beta-lipoprotein levels and outcome of hepatitis C treatment

21 January 2018

1 reference

Hepatitis C virus infection

21 January 2018

1 reference

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1002/HEP.22911

1 reference

14 December 2017

1 reference